New options for drug treatment of obesity in patients with Type 2 diabetes

Diabet Med. 2005 Sep:22 Suppl 4:23-6. doi: 10.1111/j.1464-5491.2005.1761h.x.
No abstract available

MeSH terms

  • Anti-Obesity Agents / therapeutic use*
  • Appetite Depressants / therapeutic use
  • Cannabinoids / antagonists & inhibitors
  • Cyclobutanes / therapeutic use
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Lactones / therapeutic use
  • Male
  • Middle Aged
  • Obesity / complications
  • Obesity / drug therapy*
  • Orlistat
  • Piperidines / therapeutic use
  • Pyrazoles / therapeutic use
  • Rimonabant

Substances

  • Anti-Obesity Agents
  • Appetite Depressants
  • Cannabinoids
  • Cyclobutanes
  • Hypoglycemic Agents
  • Lactones
  • Piperidines
  • Pyrazoles
  • Orlistat
  • Rimonabant
  • sibutramine